ONCITA 20mg price in UAE

Overview

Welcome to Dwaey, specifically on ONCITA 20mg Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Escitalopram (as oxalate).
ONCITA 20mg is available in the market in concentration 20mg/ml and in the form of Tablets/Film-coated.

NEOPHARMA is the producer of ONCITA 20mg and it is imported from UAE, The most popular alternatives of ONCITA 20mg are listed downward .

Mode Of Action

Escitalopram selectively inhibits CNS neuronal re-uptake of serotonin (5-HT) and potentiates serotonergic activity. It has minimal effects on norepinephrine and dopamine neuronal re-uptake.

Indication

Major depressive disorder
Depression
Panic disorder
Obsessive compulsive disorder
Anxiety disorder

Precaution

History of mania or seizure disorders; work requiring mental alertness; renal and hepatic impairment; pregnancy, lactation; withdraw gradually. Lactation Excreted in breast milk; consider risk/benefit ratio

Side Effects

>10% Headache (24%)
Nausea (18%)
Ejaculation disorder (9-14%)
Somnolence (4-13%)
Insomnia (7-12%) 1-10% Xerostomia (4-9%)
Constipation (3-6%)
Fatigue (2-8%)
Libido decrease (3-7%)
Anorgasmia (2-6%)
Flatulence (2%)
Toothache (2%)
Weight gain (1%)
Menstrual disorder (2%)
Neck/shoulder pain (3%)
Rhinitis (5%)
Flu-like syndrome (5%)
Ejaculation disorder (9-14%) <1% Arthralgia
Abdominal pain
Abnormal bleeding
Abnormal dreams
Allergy
Blurred vision
Bronchitis
Chest pain
Constipation
Decreased appetite
Decreased concentration
Disrupts platelets/hemostasis
Dizziness
Dyspepsia
Fever
Heartburn
Hot flashes
Impotence
Irritability
Jaw stiffness
Lethargy
Lightheadedness
Menstrual disorder
Hypertension
Palpitations
Migraine
Myalgia
Paresthesia
Rash
Sweating
Tinnitus
Tremor
Urinary frequency
Urinary tract infection
Vertigo
Vomiting
Yawning

Contra indication

Concomitant use with or within 2 wk of MAOI withdrawal.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Increased risk of bleeding when used with aspirin, NSAIDs or drugs that affect coagulation. Serum levels may be reduced by CYP2C19 inducers (e.g. carbamazepine, rifampin, phenytoin) or CYP3A4 inducers (e.g. nafcillin, nevirapine). Serum levels may also be increased by CYP2C19 inhibitors (e.g. fluconazole, fluvoxamine, omeprazole) or CYP3A4 inhibitors (e.g. azole antifungals, clarithromycin). May increase serum levels of desipramine or metoprolol. Increased risk of serotonin syndrome when used with linezolid or sibutramine. Escitalopram may enhance the sedative effects of alcohol. Potentially Fatal: Concomitant administration with MAOIs may lead to serious or fatal reactions; should not be started until at least 2 wk after stopping escitalopram or vice versa. Moclobemide may increase the risk of serotonin syndrome.